Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford scientists are celebrating after being given a £2m boost for medical research.

Two teams of Oxford University researchers were awarded a total of £1.3m, while Oxford University spin-out company Brainomix, which develops medical imaging software for the treatment of stroke, received £663,000.

Dr Trevor Yeung of the Nuffield Department of Surgical Sciences and his team, which includes Dr Elizabeth Bird-Lieberman of Oxford University Hospitals Trust, was awarded £634,000. Their work, which involves a fluorescent dye being sprayed on to the lining of the bowel, could help doctors distinguish between normal and cancerous tissues.

Dr Bird-Lieberman commented: 'We are delighted to receive this prestigious funding as we feel this work has potential to improve care for colon cancer. We feel that the best way to decrease cancer rates and improve outcome is by early detection and this work has the potential to do this for colon cancer.'

Researchers at the Jenner Institute working on a universal flu vaccine were awarded almost £700,000. Lead scientist Professor Sarah Gilbert said: ‘We are very pleased because it’s the next step in a programme we have been working on for a while.’

The funding comes from the Biomedical Catalyst, a joint programme run by the Medical Research Council and Innovate UK.

Similar stories

EndoNET randomises first patient of 2023

A trial investigating how effective endocrine treatment is, prior to surgery in post-menopausal women with breast cancer, has randomised its first patient of the year.

New Cochrane review on antihistamines for motion sickness

A new systematic review from Cochrane ENT at the Nuffield Department of Surgical Sciences says antihistamines are likely to reduce the risk of developing motion sickness (travel sickness) in susceptible adults under naturally occurring conditions of movement, but they may be more likely to cause drowsiness than placebo.

Life-changing results from DRWF Human Islet Isolation Facility at NDS

A new documentary film launched by the Diabetes Research and Wellness Foundation (DRWF) on World Diabetes Day 2022 features an interview with Professor Paul Johnson, as he describes life-changing results from the DRWF Human Islet Isolation Facility at the Nuffield Department of Surgical Sciences (NDS).

Blog posts

Staff Census: We need you!

All Medical Sciences staff are invited to log into HR self-service and ensure their contact, diversity background and disability details are up to date. Between 6% and 27% of staff in the Division are missing their diversity data which makes it difficult to complete statutory reporting, understand or track our population changes and to plan actions around staff diversity and equality – make sure your data is complete today!

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.